NCT01310556

Brief Summary

This study aimed to examine the prevalence of glucose metabolism disorders (GMD)in the patients with coronary artery disease and the relationship between different GMDs and coronary artery disease (CAD).

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
230

participants targeted

Target at P75+ for all trials

Timeline
Completed

Started Jun 2009

Shorter than P25 for all trials

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

June 1, 2009

Completed
1 year until next milestone

Primary Completion

Last participant's last visit for primary outcome

June 1, 2010

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

June 1, 2010

Completed
9 months until next milestone

First Submitted

Initial submission to the registry

March 7, 2011

Completed
1 day until next milestone

First Posted

Study publicly available on registry

March 8, 2011

Completed
Last Updated

June 21, 2011

Status Verified

June 1, 2009

Enrollment Period

1 year

First QC Date

March 7, 2011

Last Update Submit

June 17, 2011

Conditions

Diabetes Mellitus

Keywords

OGTTcoronary artery disease

Outcome Measures

Primary Outcomes (1)

  • Frequency of unknown glucose metabolism disorders in patients with coronary artery disease

    Results: While GMDs were detected in 58.26% (n=134 patients) of CAD patients, 41.74% of them (n=96 patients) were found to have normal glucose metabolism.

    1 year

Secondary Outcomes (1)

  • Fasting and 120 minute glucose levels have relation with vessels' stenosis.

    1 year

Study Arms (1)

coronary artery disease

patients with coronary artery disease

Other: ogtt for patients with coronary artery disease

Interventions

ogtt for patients with coronary artery diseaseOTHER

75 g OGTT

Also known as: no name
coronary artery disease

Eligibility Criteria

Age30 Years - 70 Years
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)
Sampling MethodProbability Sample
Study Population

patients with coronary artery disease and who had no glucose metabolism disorders.

You may qualify if:

  • Patients with coronary artery disease and who had no glucose metabolism disorders were included to study.

You may not qualify if:

  • Patients who had previous GMDs, malignancies, chronic liver and kidney diseases, rheumatologic disorders, and a BMI higher than 35 kg/m2 were excluded from the study.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Gulhane School of Medicine

Ankara, 06100, Turkey (Türkiye)

Location

MeSH Terms

Conditions

Diabetes MellitusCoronary Artery Disease

Interventions

Glucose Tolerance Test

Condition Hierarchy (Ancestors)

Glucose Metabolism DisordersMetabolic DiseasesNutritional and Metabolic DiseasesEndocrine System DiseasesCoronary DiseaseMyocardial IschemiaHeart DiseasesCardiovascular DiseasesArteriosclerosisArterial Occlusive DiseasesVascular Diseases

Intervention Hierarchy (Ancestors)

Blood Chemical AnalysisClinical Chemistry TestsClinical Laboratory TechniquesDiagnostic Techniques and ProceduresDiagnosisDiagnostic Techniques, EndocrineInvestigative Techniques

Study Officials

  • Aydogan Aydogdu, MD

    Gulhane School of Medicine Ankara/Turkey

    STUDY DIRECTOR

Study Design

Study Type
observational
Observational Model
CASE CONTROL
Time Perspective
PROSPECTIVE
Sponsor Type
OTHER

Study Record Dates

First Submitted

March 7, 2011

First Posted

March 8, 2011

Study Start

June 1, 2009

Primary Completion

June 1, 2010

Study Completion

June 1, 2010

Last Updated

June 21, 2011

Record last verified: 2009-06

Locations

TU(1)